Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma

By sjmartinez • April 11, 2023

Pavord ID, Deniz Y, Corren J, Casale TB, FitzGerald JM, Izuhara K, Daizadeh N, Ortiz B, Johnson RR, Harel S, Djandji M, Goga L, Crikelair N, Rowe PJ, Busse WW. Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma. J Allergy Clin Immunol Pract. 2023 Apr;11(4):1213-1220.e2. doi: 10.1016/j.jaip.2022.11.043. Epub 2022 Dec 16. PMID: 36535524.

Tags: Allergy & Immunology, asthma, Dupilumab, FEV(1), Fractional exhaled nitric oxide, Predictive biomarker, Publications, Severe exacerbations

Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkers

Riemann S, Meulmeester FL, Mailhot-Larouche S, Ramakrishnan S, Wechsler ME, Corren J, Diver SE, Brightling CE, Castro M, Hanania NA, Jackson DJ, Martin N, Laugerud[...]

UTX coordinates TCF1 and STAT3 to control progenitor CD8+ T cell fate in autoimmune diabetes

Chen HC, Bang MF, Wang HH, Shpargel KB, Kohn LA, Sailer D, Zhang S, McCarthy EC, Seyedsadr M, Stevens S, Pham CLH, Zhou Z, Yin[...]

The Possible Unveiling of Myasthenia Gravis via Allergy Shots

Thakor Philipp A, Anderson L. The Possible Unveiling of Myasthenia Gravis via Allergy Shots. Cureus. 2025 Sep 9;17(9):e91927. doi: 10.7759/cureus.91927. PMID: 41080268; PMCID: PMC12510673.